γ'/total fibrinogen ratio is associated with short-term outcome in ischaemic stroke.
Fibrinogen γ' (γ') is a natural isoform of fibrinogen, and alters the rate of formation and the properties of clots. It could therefore affect outcome after ischaemic stroke. The prognostic significance of γ' fibrinogen levels is, however, still unclear. It was the objective of this study to assess levels of γ' in ischaemic stroke, and its association with short-term outcome. We included 200 ischaemic stroke patients and 156 control persons. Total fibrinogen and γ' levels were measured; outcome at discharge was assessed by means of the modified Rankin Scale score (defined as unfavourable when >2). We compared levels between patients and controls using multiple linear regression analysis, and logistic regression analysis was used to assess the relationship between levels and outcome. All analyses were adjusted for age and sex. Mean γ' levels were significantly higher in patients with ischaemic stroke than in controls (0.37 vs. 0.32 g/l, p<0.001), and patients also had a higher γ'/total fibrinogen ratio (0.102 vs. 0.096, p=0.19). The γ'/total fibrinogen ratio is associated with unfavourable outcome in patients with ischaemic stroke (odds ratio per unit increase of γ'/total fibrinogen ratio 1.27, 95% confidence interval 1.09-1.47). Our study shows that patients with ischaemic stroke have increased levels of fibrinogen γ' and suggests a trend towards an increased γ'/total fibrinogen ratio in ischaemic stroke. Increased fibrinogen γ' relative to total fibrinogen levels are associated with unfavourable outcome in the early phase after stroke.
Erasmus MC University Medical Center, Department of Neurology, Rotterdam, The Netherlands. e.vandenherik@erasmusmc.nl
Evita G
EG
van den Herik
Elim Y L
EY
Cheung
Lonneke M L
LM
de Lau
Heleen M
HM
den Hertog
Frank W
FW
Leebeek
Diederik W J
DW
Dippel
Peter J
PJ
Koudstaal
Moniek P M
MP
de Maat
D000368:Aged; D005260:Female; D005340:Fibrinogen / Q000032:analysis* / Q000378:metabolism; D015241:Fibrinogens, Abnormal / Q000032:analysis*; D006801:Humans; D007511:Ischemia / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011379:Prognosis; D011446:Prospective Studies; D012044:Regression Analysis; D012307:Risk Factors; D020521:Stroke / Q000097:blood*; D016896:Treatment Outcome
D015241:Fibrinogens, Abnormal; C527521:fibrinogen gamma'; D005340:Fibrinogen